madman
Super Moderator
Marius Pharmaceuticals Partners with US Specialists Management, LLC (“USSM”) Through Affiliated Urologic In-office Dispensaries
RALEIGH, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for...
RALEIGH, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, has partnered with USSM, an independent physician owned/controlled Management Services Organization (“MSO”) through their Urologic in-office pharmacies and dispensaries. USSM practices include Urology Partners of North Texas, Urology of St. Louis, Urology of Iowa, Arkansas Urology, and Tennessee Valley Urology. This USSM distribution model is for KYZATREX® (testosterone undecanoate) CIII capsules, an FDA approved, cash only oral prescription drug that is used to treat adult men who have low or no testosterone levels due to certain medical conditions.
“The KYZATREX distribution model is unique because we circumvent large retail pharmacy chains and are a cash-only RX, allowing urologic practices nationwide to eliminate insurance burdens, commonly associated with testosterone,” said Polly Sawyer, Senior VP of Commercial Development at Marius.
In today’s healthcare landscape, with rampant insurance company burdens, such as prior authorizations, USSM upholds the business model of in-office dispensing, while simultaneously facilitating patient convenience and compliance.
“With USSM’s progressive ancillary focus, our goal is to maintain independence and create opportunities for our physician partners without sacrificing cash flow, administrative control, and patient care,” said Bob Yonke, CEO of USSM. “Our in-house pharmacies have been a significant component within our continued business growth.”
